FGF21 and Hepatic steatosis: First, we found that in HFD-induced obesity, warmer environmental housing temperatures improved effectiveness of FGF21/sTGFBR2 in decreasing body weight, improving insulin resistance, reducing plasma TAG, and decreasing hepatic steatosis.